First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton
Provided By GlobeNewswire
Last update: Apr 29, 2025
Approval signals important progress in U.S. market expansion as major commercial health insurers begin to follow precedent set with Medicare reimbursement for personal exoskeletons established in 2024
Read more at globenewswire.com0.7301
-0.01 (-1.82%)
Find more stocks in the Stock Screener
LFWD Latest News and Analysis
